References
- Luft B J, Remington J S. Toxoplasmic encephalitis. J Infect Dis 1988; 157: 1–6
- Luft B J, Hafner R. Toxoplasmic encephalitis. AIDS 1990; 4: 593–595
- Levy R M, Bredesen D E, Rosenblum M L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience of UCSF and review of the literature. J Neurosurg 1985; 62: 475–495
- Haverkos H W, The Toxoplasma Encephalitis Study Group. Assessment of therapy for Toxoplasma encephalitis. Am J Med 1987; 82: 907–914
- Leport C, Raffi F, Matheron S, Katlama C, Regnier B, Saimot A G, Marche C, Vedrenne C, Vilde J L. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Am J Med 1988; 84: 94–100
- Levy R M, Rosenbloom S, Perrett L V. Neuroradiologic findings in AIDS: A review of 200 cases. AJR 1986; 147: 977–983
- Luft B J, Brooks R G, Conley F K, McCabe R E, Remington J S. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA 1984; 252: 913–917
- Luft B J, Conley F, Remington J S. Outbreak of central nervous‐system toxoplasmosis in Western Europe and North America. Lancet 1983; 1: 781–784
- Wanke C, Tuazon C U, Kovacs A, Dina T, Davis D O, Barton N, Katz D, Lunde M, Levy C, Conley F K, Lane H C, Fauci A S, Masur H. Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: Diagnosis and response to therapy. Am J Trop Med Hyg 1987; 36: 509–516
- Andersen B J, Pedersen N S. Toxoplasmose. EPI‐NYT, Statens Seruminstitut, uge. 1987; 38, (In Danish.)
- Centers for Disease Control. Revision of the case definition of acquired immunodeficiency syndrome for national reporting. MMWR 1985; 34: 374–375
- Centers for Disease Control. Revision of the CDC surveillance case definition of the acquired immunodeficiency syndrome. MMWR 1987; 36(Suppl. S‐1)
- McCabe R, Remington J S. Toxoplasmosis: The time has come. N Engl J Med 1988; 318: 313–315
- Townsend J J, Wolilnsky J S, Baringer R J, Johnson P C. Acquired toxoplasmosis. A neglected cause of treatable nervous system disease. Arch Neurol 1975; 32: 335–343
- Selik M R, Stracher E T, Curran J W. Opportunistic diseases reported in AIDS patients: Frequencies, associations, and trends. AIDS 1987; 1: 175–182
- Smith E, Orholm M. Trends and patterns of opportunistic diseases in Danish AIDS patients 1980–1990. Scand J Infect Dis 1990; 22: 665–672
- Pedrol E, Gonzàlez‐Clemente J M, Gatell J M, Mallolas J, Miró J M, Graus F, Alvarez R, Mercader J M, Berenguer J, de Anta M TJ, Valls M E, Soriano E. Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy. AIDS 1990; 4: 511–517
- Potsman I, Resnick L, Luft B J, Remington J S. Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 108: 49–51
- Weiss L M, Udem S A, Tanowitz H, Wittner M. Western blot analysis of the antibody response of patients with AIDS and toxoplasma encephalitis: Antigenic diversity among toxoplasma strains. J Infect Dis 1988; 157: 7–13
- Holliman R E, Johnson J D, Savva D. Diagnosis of cerebral toxoplasmosis in association with AIDS using the polymerase chain reaction. Scand J Infect Dis 1990; 22: 243–244
- Weiss L M, Harris C, Berger M, Tanowitz H, Wittner M. Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute toxoplasma encephalitis in patients with AIDS. J Infect Dis 1988; 157: 580–584
- Harris C, Salgo M, Tanowitz H B, Wittner M. In vitro assessment of antimicrobial agents against Toxoplasma gondii. J Infect Dis 1988; 157: 14–22